Data / Drug companies / Guaifenesin and dextromethorphan hydrobromide
Guaifenesin and dextromethorphan hydrobromide: 13 companies and 20 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guaifenesin and dextromethorphan hydrobromide is listed in the FDA National Drug Code Directory by 13 companies, with 20 products in commercial distribution. 2 of the products (10.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; syrup; tablet, and the newest product started marketing on April 1, 2024.
The request: Get every company that lists guaifenesin and dextromethorphan hydrobromide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 20
- Generic (ANDA) products
- 2 (10.0%)
- Application numbers
- 3
- Routes
- Oral
- Brand names
- Mucinex DM, Mucinex DM Maximum Strength, Mucinex DM, Travel Basix, Mucinex DM, Childrens Mucus and Cough Relief, Mucus Relief DM, Guaifenesin DM, HBP Chest Congestion and Cough Relief
- openFDA record search
- api.fda.gov
Companies that list guaifenesin and dextromethorphan hydrobromide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 3 | tablet, extended release | New drug applications (NDA) | June 26, 2012 |
| Lil' Drug Store Products, Inc. | 3 | tablet, extended release | New drug applications (NDA) | November 29, 2022 |
| Method Pharmaceuticals, LLC | 2 | syrup | Over the counter monograph drugs | April 1, 2024 |
| Reckitt Benckiser LLC | 2 | tablet, extended release | New drug applications (NDA) | June 26, 2012 |
| Walgreen Company | 2 | capsule, liquid filled | Over the counter monograph drugs | February 19, 2024 |
| Bryant Ranch Prepack | 1 | syrup | Over the counter monograph drugs | April 1, 2024 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | tablet, extended release | Generic drugs (ANDA) | April 19, 2022 |
| Chain Drug Marketing Association | 1 | liquid | Over the counter monograph drugs | October 19, 2015 |
| InvaTech Pharma Solutions LLC | 1 | tablet | Over the counter monograph drugs | January 13, 2021 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Over the counter monograph drugs | April 2, 2018 |
| Rite Aid Corporation | 1 | tablet, extended release | Generic drugs (ANDA) | June 28, 2022 |
| Select Consumer Group | 1 | tablet, extended release | New drug applications (NDA) | June 26, 2012 |
| Sportpharm LLC | 1 | tablet, extended release | New drug applications (NDA) | June 26, 2012 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 12 | 60% |
| Syrup | 3 | 15% |
| Tablet | 2 | 10% |
| Capsule, liquid filled | 2 | 10% |
| Liquid | 1 | 5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 10 | 50% |
| Over the counter monograph drugs | 8 | 40% |
| Generic drugs (ANDA) | 2 | 10% |
Pharmacologic classes
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.